Key result
Plasma cholesterol and triglyceride levels were not correlated with cognitive function assessments, although regression analysis suggested they may be prognostic factors for cognitive impairment.
Why the study?
Are plasma cholesterol and triglyceride levels correlated with cognitive functions and neurotization in patients with chronic cerebral ischemia and psychosomatic illnesses?
Observational (n=110)
Are plasma cholesterol and triglyceride levels correlated with cognitive functions and neurotization in patients with chronic cerebral ischemia and psychosomatic illnesses?
In patients with chronic cerebral ischemia and psychosomatic illnesses, lipid levels did not directly correlate with cognitive function scores but may serve as prognostic factors for cognitive impairment.
Answers are grounded in this paper and cite their sources.
Lipid-psychometric correlations in CCI merit prospective validation; leaves open any therapeutic implications for lipid management.
OBJECTIVE: To explore the correlations between plasma cholesterol and triglyceride levels and psychometric assessments in patients with psychosomatic illnesses and chronic cerebral ischemia (CCI). MATERIAL AND METHODS: One hundred and ten patients (51% women, 49% men), aged from 46 to 76 years (mean 65.1 years) with CCI were examined. The study included cholesterol and triglyceride tests and a battery of tests for assessment of cognitive functions and neurotization level. RESULTS: Cholesterol levels were higher in patients with post-infarct cardiosclerosis (PICS) compared to the comparison group but did not differ from those of patients with peptic ulcer disease (PUD). Triglyceride levels were high in both psychosomatic groups, with higher levels in the patients with PICS compared to the patients with PUD. Plasma cholesterol and triglyceride levels were not correlated with assessments of cognitive functions in patients of different age. CONCLUSION: Cognitive impairment and higher level of neurotization were characteristic of patients with psychosomatic illnesses. Regression analysis has demonstrated that plasma cholesterol and triglyceride levels may be a prognostic factor for cognitive impairment.
No takes yet. Share an insight, caveat, or question.
Шевченко et al. (2015) conducted an observational in Psychosomatic illnesses and chronic cerebral ischemia (n=110). Plasma cholesterol and triglyceride levels was evaluated on Correlation between plasma lipid levels and psychometric assessments. Plasma cholesterol and triglyceride levels were not correlated with cognitive function assessments, although regression analysis suggested they may be prognostic factors for cognitive impairment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: